miR-519d-mediated downregulation of STAT3 suppresses breast cancer progression

被引:45
作者
Deng, Xin [1 ]
Zhao, Yi [1 ]
Wang, Baosheng [1 ]
机构
[1] China Med Univ, Shengjing Hosp, Dept Pancreat & Breast Surg, Shenyang 110004, Liaoning, Peoples R China
关键词
miR-519d; STAT3; breast cancer; metastasis; apoptosis; PROMOTES TUMOR-METASTASIS; EXPRESSION; MIR-519D; TARGETS; ROLES; PROLIFERATION; TRANSCRIPTION; MICRORNAS; PATHWAY;
D O I
10.3892/or.2015.4160
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
MicroRNAs (miRNAs) play important roles in the the gene regulation of carcinogenesis including breast cancer. miR-519d has been studied in various types of cancer, but its role in breast cancer remains unclear. In the present study, we investigated the expression and biological function of miR519d in breast cancer. Using quantitative RT-PCR (RT-qPCR) analysis, we analyzed the expression of miR-519d in breast cancer tissues and cell lines. It was shown that miR-519d expression was decreased in cancer tissues and cell lines compared with their controls. Overexpression of miR-519d inhibited cell proliferation and invasion, and induced apop.tosis of breast cancer cells. Signal transducer and activator of transcription 3 (STAT3) was predicted as a target gene of miR-519d and it was verified by the luciferase reporter assay. Additionally, STAT3 mRNA and protein expression levels were downregulated in the cells with miR-519d overexpression as determined by RT-qPCR and western blotting. Taken together, the results indicated that miR-519d functions as a tumor suppressor in breast cancer by suppressing STAT3 expression.
引用
收藏
页码:2188 / 2194
页数:7
相关论文
共 22 条
  • [1] Roles and regulation of Stat family transcription factors in human breast cancer
    Clevenger, CV
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2004, 165 (05) : 1449 - 1460
  • [2] Intracellular and Extracellular MicroRNAs in Breast Cancer
    Corcoran, Claire
    Friel, Anne M.
    Duffy, Michael J.
    Crown, John
    O'Driscoll, Lorraine
    [J]. CLINICAL CHEMISTRY, 2011, 57 (01) : 18 - 32
  • [3] In hepatocellular carcinoma miR-519d is up-regulated by p53 and DNA hypomethylation and targets CDKN1A/p21, PTEN, AKT3 and TIMP2
    Fornari, Francesca
    Milazzo, Maddalena
    Chieco, Pasquale
    Negrini, Massimo
    Marasco, Elena
    Capranico, Giovanni
    Mantovani, Vilma
    Marinello, Jessica
    Sabbioni, Silvia
    Callegari, Elisa
    Cescon, Matteo
    Ravaioli, Matteo
    Croce, Carlo M.
    Bolondi, Luigi
    Gramantieri, Laura
    [J]. JOURNAL OF PATHOLOGY, 2012, 227 (03) : 275 - 285
  • [4] Greene SB, 2010, CURR DRUG TARGETS, V11, P1059
  • [5] Haghikia Arash, 2012, JAKSTAT, V1, P143, DOI 10.4161/jkst.19573
  • [6] Mechanisms of Disease: insights into the emerging role of signal transducers and activators of transcription in cancer
    Haura, EB
    Turkson, J
    Jove, R
    [J]. NATURE CLINICAL PRACTICE ONCOLOGY, 2005, 2 (06): : 315 - 324
  • [7] MicroRNA-519d targets MKi67 and suppresses cell growth in the hepatocellular carcinoma cell line QGY-7703
    Hou, Yan-Yan
    Cao, Wei-Wei
    Li, Lan
    Li, Sheng-Ping
    Liu, Tao
    Wan, Hai-Ying
    Liu, Min
    Li, Xin
    Tang, Hua
    [J]. CANCER LETTERS, 2011, 307 (02) : 182 - 190
  • [8] Cancer statistics, 2007
    Jemal, Ahmedin
    Siegel, Rebecca
    Ward, Elizabeth
    Murray, Taylor
    Xu, Jiaquan
    Thun, Michael J.
    [J]. CA-A CANCER JOURNAL FOR CLINICIANS, 2007, 57 (01) : 43 - 66
  • [9] MiR-1181 inhibits stem cell-like phenotypes and suppresses SOX2 and STAT3 in human pancreatic cancer
    Jiang, Jianxin
    Li, Zhu
    Yu, Chao
    Chen, Meiyuan
    Tian, Se
    Sun, Chengyi
    [J]. CANCER LETTERS, 2015, 356 (02) : 962 - 970
  • [10] Micro-RNAs and breast cancer
    Le Quesne, John
    Caldas, Carlos
    [J]. MOLECULAR ONCOLOGY, 2010, 4 (03) : 230 - 241